AMA CPT® Assistant - 2021 Issue 10 (October)
New COVID-19 Vaccine Codes: October Update (October 2021)
October 2021 Special Edition New COVID-19 Vaccine Codes: October Update Recently, new Current Procedural Terminology (CPT ®) codes for a ready-to-use vaccine product (tris-sucrose formulation) from Pfizer and its administration were added to previously established vaccine codes for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]). The CPT Editorial Panel (the Panel) has approved a new vaccine product code and its associated administration codes of the reformulated Pfizer vaccine product for pediatric use. This reformulated vaccine product involves the administration of two intramuscular injections of a diluted and reconstituted dosage of 10 mcg/0.2 mL volume...
Subscribe or sign in to view the full article.
Article Overview
This special edition article explains October 2021 CPT vaccine coding updates for COVID-19, including the new pediatric Pfizer vaccine product and its associated administration codes. It is aimed at coders, billers, and clinical staff who need to understand the updated CPT structure, related appendix changes, and general reporting guidance for COVID-19 vaccination encounters, including situations involving other vaccines.
Why This Topic Matters
The update helps readers stay current with newly established CPT vaccine codes and the surrounding reporting framework so they can identify the correct vaccine product and administration categories in COVID-19 immunization encounters.
Article Sections
-
October 2021 Special Edition
Introductory special-edition context for the CPT vaccine coding update and its focus area.
-
Immunization Administration for Vaccines/Toxoids
CPT immunization administration updates and related reporting guidance for COVID-19 vaccine administration codes.
-
Vaccines, Toxoids
CPT vaccine product code updates associated with COVID-19 vaccine formulations and their administration relationships.
-
Clinical Example (91307) / Description of Procedure (91307)
A clinical scenario and procedural context tied to the new pediatric vaccine product code.
-
Clinical Example (0071A) / Description of Procedure (0071A)
A clinical scenario and procedural context tied to the first-dose administration code for the pediatric vaccine product.
-
Clinical Example (0072A) / Description of Procedure (0072A)
A clinical scenario and procedural context tied to the second-dose administration code for the pediatric vaccine product.
-
Frequently Asked Questions
Common questions about reporting the new COVID-19 vaccine codes and their interaction with other vaccine services.
What You Will Learn
- How the October 2021 CPT vaccine update is organized
- Which COVID-19 vaccine coding areas were revised or added
- How the article frames the new pediatric Pfizer vaccine code set
- What types of supporting guidance are included for immunization encounters
- How the update addresses coding considerations when COVID-19 vaccination occurs alongside other vaccines
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Clinical documentation staff
- Immunization program staff
- Physicians and other qualified health care professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
